Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortAromatase inhibitor for breast cancer treatment and prevention.Breast cancer hormone therapy after menopause; also a fertility drug.
Body systemCancerCancer
Drug classAromatase inhibitorsAromatase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesBreast cancer after menopause, Breast cancer prevention (high risk)Hormone-receptor-positive breast cancer after menopause, Ovulation induction in PCOS (off-label)
How it worksCuts oestrogen levels after menopause.Shuts down oestrogen production after menopause.
Starts working——
Half-lifeAbout 50 hoursAbout 2 days
Typical adult dose1 mg once a day.Breast cancer: 2.5 mg once a day for 5–10 years.
FormsTabletTablet
Common side effectsHot flushes, Joint pain, TirednessJoint and muscle pain, Hot flushes, Fatigue, Raised cholesterol
Serious side effectsBone thinning, Severe skin reactions (rare)Bone loss and fractures, Heart problems (rare)
Don't take if——
Alcohol——
PregnancyUsually avoidedNot for use in pregnancy.Usually avoidedContraindicated in pregnancy (fertility use is before conception).
Breastfeeding——
In use since19951996
Brand namesUnited States: ArimidexUnited Kingdom: ArimidexIndia: Armotraz, AltrazUnited States: FemaraUnited Kingdom: FemaraIndia: Letroz, Femara, Letoval
Legal status——
ATC codeL02BG03L02BG04

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker